[1]Gubernot D M, Lucey C T, Lee K C, Conley G B, Holness L G, Wise R P. Babesia Infection through Blood Transfusions: Reports Received by the US Food and Drug Administration, 1997-2007. Clinical Infectious Diseases, 2009, 48:25-30.[2]Haselbarth K, Tenter A M, Brade V, Krieger G, Hunfeld K P. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen. International Journal of Medical Microbiology, 2007, 297(3): 197-204.[3]Schnittger L, Rodriguez A E, Florin-Christensen M, Morrison D A. Babesia: a world emerging. Infection, Genetics and Evolution, 2012, 12(8): 1788-1809.[4]Vial H J, Gorenflot A. Chemotherapy against babesiosis. Veterinary Parasitology, 2006, 138(1-2): 147-160.[5]Hunfeld K P, Hildebrandt A, Gray J S. Babesiosis: recent insights into an ancient disease. International Journal for Parasitology, 2008, 38(11): 1219-1237.[6]Lau A O. An overview of the Babesia, Plasmodium and Theileria genomes: a comparative perspective. Molecular and Biochemical Parasitology, 2009, 164(1): 1-8.[7]Vial H J. Isoprenoid biosynthesis and drug targeting in the Apicomplexa. Parasitol Today, 2000, 16(4): 140-141, Wiesner J, Jomaa H. Isoprenoid biosynthesis of the apicoplast as drug target. Current Drug Targets, 2007, 8(1): 3-13.[8]Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Turbachova I, Eberl M, Zeidler J, Lichtenthaler H K, Soldati D, Beck E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science, 1999, 285(5433): 1573-1576.[9]Xue J, Ahring B K. Enhancing isoprene production by genetic modification of the 1-deoxy-d-xylulose-5-phosphate pathway in Bacillus subtilis. Applied and Environmental Microbiology, 2011, 77(7): 2399-2405.[10]Xiang S, Usunow G, Lange G, Busch M, Tong L. Crystal structure of 1-deoxy-D-xylulose 5-phosphate synthase, a crucial enzyme for isoprenoids biosynthesis. Journal of Biological Chemistry, 2007, 282(4): 2676-2682.[11]Handa S, Ramamoorthy D, Spradling T J, Guida W C, Adams J H, Bendinskas K G, Merkler D J. Production of recombinant 1-deoxy-d-xylulose-5-phosphate synthase from Plasmodium vivax in Escherichia coli. FEBS Open Bio, 2013, 3:124-129.[12]Schwender J, Muller C, Zeidler J, Lichtenthaler H K. Cloning and heterologous expression of a cDNA encoding 1-deoxy-D-xylulose- 5-phosphate reductoisomerase of Arabidopsis thaliana. FEBS Letters, 1999, 455(1-2): 140-144.[13]Querol J, Besumbes O, Lois L M, Boronat A, Imperial S. A fluorometric assay for the determination of 1-deoxy-D-xylulose 5-phosphate synthase activity. Analytical Biochemistry, 2001, 296(1): 101-105.[14]Han Y S, Sabbioni C, van der Heijden R, Verpoorte R. High- performance liquid chromatography assay for 1-deoxy-D-xylulose 5-phosphate synthase activity using fluorescence detection. Journal of Chromatography A, 2003, 986(2): 291-296.[15]Frearson J A, Wyatt P G, Gilbert I H, Fairlamb A H. Target assessment for antiparasitic drug discovery. Trends in Parasitology, 2007, 23(12): 589-595.[16]Roos D S, Crawford M J, Donald R G, Kissinger J C, Klimczak L J, Striepen B. Origin, targeting, and function of the apicomplexan plastid. Current Opinion in Microbiology, 1999, 2(4): 426-432.[17]Wiesner J, Reichenberg A, Heinrich S, Schlitzer M, Jomaa H. The plastid-like organelle of apicomplexan parasites as drug target. Current Pharmaceutical Design, 2008, 14(9): 855-871.[18]Aboulaila M, Munkhjargal T, Sivakumar T, Ueno A, Nakano Y, Yokoyama M, Yoshinari T, Nagano D, Katayama K, El-Bahy N, Yokoyama N, Igarashi I. Apicoplast-targeting antibacterials inhibit the growth of Babesia parasites. Antimicrobial Agents and Chemotherapy, 2012, 56(6): 3196-3206.[19]Ramya T N, Mishra S, Karmodiya K, Surolia N, Surolia A. Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy, 2007, 51(1): 307-316.[20]Brayton K A, Lau A O, Herndon D R, Hannick L, Kappmeyer L S, Berens S J, Bidwell S L, Brown W C, Crabtree J, Fadrosh D, Feldblum T, Forberger H A, Haas B J, Howell J M, Khouri H, Koo H, Mann D J, Norimine J, Paulsen I T, Radune D, Ren Q, Smith R K, Jr., Suarez C E, White O, Wortman J R, Knowles D P, Jr., McElwain T F, Nene V M. Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathogens, 2007, 3(10): 1401-1413.[21]Caballero M C, Pedroni M J, Palmer G H, Suarez C E, Davitt C, Lau A O. Characterization of acyl carrier protein and LytB in Babesia bovis apicoplast. Molecular and Biochemical Parasitology, 2012, 181(2): 125-133.[22]Mao J, Eoh H, He R, Wang Y, Wan B, Franzblau S G, Crick D C, Kozikowski A P. Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase. Bioorganic & Medicinal Chemistry Letters, 2008, 18(19): 5320-5323.[23]Hayashi D, Kato N, Kuzuyama T, Sato Y, Ohkanda J. Antimicrobial N-(2-chlorobenzyl)-substituted hydroxamate is an inhibitor of 1-deoxy-D-xylulose 5-phosphate synthase. Chemical Communications, 2013, 49(49): 5535-5537.[24]Matsue Y, Mizuno H, Tomita T, Asami T, Nishiyama M, Kuzuyama T. The herbicide ketoclomazone inhibits 1-deoxy-D-xylulose 5-phosphate synthase in the 2-C-methyl-D-erythritol 4-phosphate pathway and shows antibacterial activity against Haemophilus influenzae. The Journal of Antibiotics, 2010, 63(10): 583-588.[25]Hawkins C F, Borges A, Perham R N. A common structural motif in thiamin pyrophosphate-binding enzymes. FEBS Letters, 1989, 255(1): 77-82. |